Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000320017-25-000070
Filing Date
2025-11-06
Accepted
2025-11-06 16:16:04
Documents
85
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lsta-20250930.htm   iXBRL 10-Q 1103981
2 EX-31.1 lsta-ex311_20250930.htm EX-31.1 9440
3 EX-31.2 lsta-ex312_20250930.htm EX-31.2 9482
4 EX-32.1 lsta-ex321_20250930.htm EX-32.1 6730
5 EX-32.2 lsta-ex322_20250930.htm EX-32.2 6807
11 lsta-20250930_g1.jpg GRAPHIC 175784
  Complete submission text file 0000320017-25-000070.txt   7429597

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lsta-20250930.xsd EX-101.SCH 54403
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lsta-20250930_cal.xml EX-101.CAL 59492
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lsta-20250930_def.xml EX-101.DEF 209251
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lsta-20250930_lab.xml EX-101.LAB 693882
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lsta-20250930_pre.xml EX-101.PRE 464332
88 EXTRACTED XBRL INSTANCE DOCUMENT lsta-20250930_htm.xml XML 954298
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33650 | Film No.: 251458517
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)